Shunqiang Li, PhD

Shunqiang Li, PhD

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine

Research Interest

1) Establishment and characterization of patient-derived xenograft (PDX) models, 2) PDX-based preclinical testing of new anticancer drugs and treatments, 3) Application of PDX models to cancer translation research, including tumorigenesis, resistance, metastasis, and biomarker, 4) HAMLET core service

Education

  • 1999: PhD, pharmacology, Chinese Academy of Medical Sciences and Peking Union Medical College, P.R. China

Training

  • 1999 - 2002: Postdoctoral research, Fred Hutchinson Cancer Research Center, Seattle
  • 2002 - 2004: Postdoctoral research, University of North Carolina at Chapel Hill

Selected Research Publications

Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library.
  • Singh AK, Lewis CD, Boas CAWV, [...] Li S, [...] Hallahan DE
  • Clin Cancer Res 2024
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer.
  • Gou X, Kim BJ, Anurag M, [...] Li S, [...] Ellis MJ
  • Cancer Res 2023
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
  • Anurag M, Jaehnig EJ, Krug K, [...] Li S, [...] Ellis MJ
  • Cancer Discov 2022

View All Publications